Of these, 189 patients had tumor markers recorded during the study period, including 58 patients with CEA values, 47 patients with CA 19–9 values, 39 patients with CA 125 values, and 45 patients with CA 27–29 values. The gene discussed is CEACAM5; the disease is neoplasm.